146 related articles for article (PubMed ID: 17586589)
21. [A new marker for the diagnosis of rheumatoid arthritis: cyclic citrullinated peptide antibodies (anti-CCP)].
Altindiş M
Mikrobiyol Bul; 2003 Oct; 37(4):313-8. PubMed ID: 14748270
[TBL] [Abstract][Full Text] [Related]
22. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.
Vossenaar ER; Després N; Lapointe E; van der Heijden A; Lora M; Senshu T; van Venrooij WJ; Ménard HA
Arthritis Res Ther; 2004; 6(2):R142-50. PubMed ID: 15059278
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
24. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
Brink M; Hansson M; Mathsson L; Jakobsson PJ; Holmdahl R; Hallmans G; Stenlund H; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
Arthritis Rheum; 2013 Apr; 65(4):899-910. PubMed ID: 23310951
[TBL] [Abstract][Full Text] [Related]
25. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
Al-Jarallah K; Shehab D; Al-Attiyah R; Al-Azmi W; Al-Fadli A; Zafar Haider M; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2012 Sep; 18(9):1655-62. PubMed ID: 22114016
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
[TBL] [Abstract][Full Text] [Related]
28. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis.
Pérez ML; Gómara MJ; Ercilla G; Sanmartí R; Haro I
J Med Chem; 2007 Jul; 50(15):3573-84. PubMed ID: 17585853
[TBL] [Abstract][Full Text] [Related]
30. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis.
Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J
Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.
Qin X; Deng Y; Xu J; Li TJ; Li S; Zhao JM
Rheumatol Int; 2011 Jun; 31(6):785-94. PubMed ID: 20221607
[TBL] [Abstract][Full Text] [Related]
32. Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies.
Sorice M; Iannuccelli C; Manganelli V; Capozzi A; Alessandri C; Lococo E; Garofalo T; Di Franco M; Bombardieri M; Nerviani A; Misasi R; Valesini G
Rheumatology (Oxford); 2016 Aug; 55(8):1374-85. PubMed ID: 27074807
[TBL] [Abstract][Full Text] [Related]
33. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
35. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor.
Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F
Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613
[TBL] [Abstract][Full Text] [Related]
36. The use of citrullinated peptides for the diagnosis and prognosis of rheumatoid arthritis.
Haro I; Gómara MJ
Curr Top Med Chem; 2014; 14(23):2729-33. PubMed ID: 25515746
[TBL] [Abstract][Full Text] [Related]
37. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
38. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide.
El-Barbary AM; Kassem EM; El-Sergany MA; Essa SA; Eltomey MA
J Rheumatol; 2011 May; 38(5):828-34. PubMed ID: 21362765
[TBL] [Abstract][Full Text] [Related]
39. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
Syversen SW; Goll GL; van der Heijde D; Landewé R; Lie BA; Odegård S; Uhlig T; Gaarder PI; Kvien TK
Ann Rheum Dis; 2010 Feb; 69(2):345-51. PubMed ID: 19648126
[TBL] [Abstract][Full Text] [Related]
40. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
